Excited to share our new paper is now out in #Atherosclerosis:
In patients with #ASCVD, adding #bioADM to the ESC-recommended #SMART risk score improves risk prediction and model performance.
Thanks to all collaborators for the joint effort.
Read here (open access): tinyurl.com/3jtdhpzv
In patients with #ASCVD, adding #bioADM to the ESC-recommended #SMART risk score improves risk prediction and model performance.
Thanks to all collaborators for the joint effort.
Read here (open access): tinyurl.com/3jtdhpzv
Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD
Bioactive adrenomedullin 1-52 (bio-ADM) is a novel biomarker for the assessment of
endothelial function and prediction of adverse outcomes in patients with acute heart
failure and cardiogenic shock. T...
tinyurl.com
May 30, 2025 at 8:50 AM
Excited to share our new paper is now out in #Atherosclerosis:
In patients with #ASCVD, adding #bioADM to the ESC-recommended #SMART risk score improves risk prediction and model performance.
Thanks to all collaborators for the joint effort.
Read here (open access): tinyurl.com/3jtdhpzv
In patients with #ASCVD, adding #bioADM to the ESC-recommended #SMART risk score improves risk prediction and model performance.
Thanks to all collaborators for the joint effort.
Read here (open access): tinyurl.com/3jtdhpzv